Pharmacotyping of hypokalaemic salt-losing tubular disorders

Acta Physiologica Scandinavica

Volumn 181, Issue 4, 2004, Pages 513-521

  Reinalter, S C ^a   Jeck, N ^a   Peters, M ^a   Seyberth, H W ^a,b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Department of Paediatrics ^*  (Germany)

Author keywords

Bartter syndrome; Gitelman syndrome; Hyperprostaglandin E syndrome; Pharmacotyping; Salt losing tubular disorders; Terminology

Indexed keywords

AMILORIDE; CHLORIDE CHANNEL; FUROSEMIDE; POTASSIUM CHANNEL; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; THIAZIDE DIURETIC AGENT;

BARTTER SYNDROME; BETA CHAIN; CLINICAL FEATURE; CONFERENCE PAPER; DRUG MECHANISM; ELECTROLYTE TRANSPORT; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GITELMAN SYNDROME; HUMAN; HYDRAMNIOS; HYPERALDOSTERONISM; HYPERCALCIURIA; HYPOCALCIURIA; HYPOKALEMIA; HYPOKALEMIC ALKALOSIS; HYPOMAGNESEMIA; KIDNEY TUBULE DISORDER; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SALT LOSING NEPHRITIS; WATER LOSS;

BARTTER SYNDROME; DIURETICS; GENOTYPE; HUMANS; HYPOKALEMIA; PHENOTYPE; RENAL TUBULAR TRANSPORT, INBORN ERRORS; TERMINOLOGY;

EID: 4043121815     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-201X.2004.01325.x     Document Type: Conference Paper

References (47)

1. Ando, A., Koshida, H., Morise, T. et al. 1985. Pseudo-Bartter's syndrome and surreptitious abuse of furosemide in a woman complicated with masked idiopathic edema and defective character. Nippon Jinzo Gakkai Shi 27, 519-524.
2. Bartter, F.C., Pronove, P., Gill, J.R.J., MacCardle, R.C. & Diller, E. 1962. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis - a new syndrome. Am J Med 33, 811-828.
3. Bartter, F.C., Gill, J.R. Jr, Frolich, J.C. et al. 1976. Prostaglandins are overproduced by the kidneys and mediate hyperreninemia in Bartter's syndrome. Trans Assoc Am Physicians 89, 77-91.
4. Bartter, F.C., Pronove, P., Gill, J.R. Jr. et al. 1998. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome 1962. J Am Soc Nephrol 9, 516-528.
5. Bettinelli, A., Bianchetti, M.G., Girardin, E. et al. 1992. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 120, 38-43.
6. Bettinelli, A., Rusconi, R., Ciarmatori, S. et al. 1999. Gitelman disease associated with growth hormone deficiency, disturbances in vasopressin secretion and empty sella: a new hereditary renal tubular-pituitary syndrome? Pediatr Res 46, 232-238.
7. Birkenhager, R., Otto, E., Schurmann, M.J. et al. 2001. Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 29, 310-314.
8. Boer, W.H., Hené, R.J., Koomans, H.A. & Dorhout Mees, E.J. 1994. Discrepancy between lithium and free water clearance in patients with Bartter's syndrome. Nephron 67, 82-87.
9. Brennan, T.M., Landau, D., Shalev, H. et al. 1998. Linkage of infantile Bartter syndrome with sensorineural deafness to chromosome 1p. Am J Hum Genet 62, 355-361.
10. Colussi, G., Rombola, G., Verde, G. et al. 1992. Distal nephron function in Bartter's syndrome: abnormal conductance to chloride in the cortical collecting tubule? Am J Nephrol 12, 229-239.
11. Cruz, D.N., Shaer, A.J., Bia, M.J., Lifton, R.P. & Simon, D.B. 2001. Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 59, 710-717.
12. Demers, L.M., Veldhuis, J.D. & Ramos, E. 1980. The clinical entity of pseudo-Bartter's syndrome. Adv Prostaglandin Thromboxane Res 7, 1203-1206.
13. Derst, C., Konrad, M., Kockerling, A. et al. 1997. Mutations in the ROMK gene in antenatal Bartter syndrome are associated with impaired K+ channel function. Biochem Biophys Res Commun 230, 641-645.
14. Estevez, R., Boettger, T., Stein, V. et al. 2001. Barttin is a Cl-channel beta-subunit crucial for renal Cl- reabsorption and inner ear K+ secretion. Nature 414, 558-561.
15. Fanconi, A., Schachenmann, G., Nüssli, R. & Prader, A. 1971. Chronic Hypokalaemia with growth retardation, normotensive hyperrenin- hyperaldosteronism ('Bartter's syndrome'), and hypercalciuria. Report of two cases with emphasis on natural history and on catch-up growth during treatment. Helv Paediat Acta 2, 144-163.
16. Finer, G., Shalev, H., Birk, O.S. et al. 2003. Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome. J Pediatr 142, 318-323.
17. Gitelman, H.J., Graham, J.B. & Welt, L.G. 1966. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 79, 221-223.
18. Hakguder, G., Ates, O., Olguner, M. et al. 2002. Induction of fetal diuresis with intraamniotic furosemide increases the clearance of intraamniotic substances: an alternative therapy aimed at reducing intraamniotic meconium concentration. J Pediatr Surg 37, 1337-1342.
19. International Study Group for Bartter-like syndromes, Károlyi, L., Konrad, M. et al. 1997. Mutations in the gene encoding the inwardly-rectifying renal potassium channel, ROMK, cause the antenatal variant of Bartter syndrome: evidence for genetic heterogeneity. International Collaborative Study Group for Bartter-like Syndromes. Hum Mol Genet 6, 17-26.
20. Jeck, N., Konrad, M., Peters, M. et al. 2000. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res 48, 754-758.
21. Jeck, N., Reinalter, S.C., Henne, T. et al. 2001. Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness. Pediatrics 108, E5.
22. Kammerl, M.C., Nusing, R.M., Schweda, F. et al. 2001. Low sodium and furosemide-induced stimulation of the renin system in man is mediated by cyclooxygenase 2. Clin Pharmacol Ther 70, 468-474.
23. Kelly, T.F., Moore, T.R. & Brace, R.A. 1993. Hemodynamic and fluid responses to furosemide infusion in the ovine fetus. Am J Obstet Gynecol 168, 260-268.
24. Kockerling, A., Reinalter, S.C. & Seyberth, H.W. 1996. Impaired response to furosemide in hyperprostaglandin E syndrome: evidence for a tubular defect in the loop of Henle. J Pediatr 129, 519-528.
25. Konrad, M., Vollmer, M., Lemmink, H.H. et al. 2000. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 11, 1449-1459.
26. Landau, D., Shalev, H., Ohaly, M. & Carmi, R. 1995. Infantile variant of Bartter syndrome and sensorineural deafness: a new autosomal recessive disorder. Am J Med Genet 59, 454-459.
27. McCredie, D.A., Blair-West, J.R., Scoggins, B.A. & Shipman, R. 1971. Potassium-losing nephropathy of childhood. Med J Aust 1, 129-135.
28. Miyanoshita, A., Terada, M. & Endou, H. 1989. Furosemide directly stimulates prostaglandin E2 production in the thick ascending limb of Henle's loop. J Pharmacol Exp Ther 251, 1155-1159.
29. Ohlsson, A., Sieck, U., Cumming, W., Akhtar, M. & Serenius, F. 1984. A variant of Bartter's syndrome. Bartter's syndrome associated with hydramnios, prematurity, hypercalciuria and nephrocalcinosis. Acta Paediatr Scand 73, 868-874.
30. Peters, M., Jeck, N., Reinalter, S. et al. 2002. Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 112, 183-190.
31. Peti-Peterdi, J., Komlosi, P., Fuson, A.L. et al. 2003. Luminal NaCl delivery regulates basolateral PGE2 release from macula densa cells. J Clin Invest 112, 76-82.
32. Puschett, J.B., Greenberg, A., Mitro, R., Piraino, B. & Wallia, R. 1988. Variant of Bartter's syndrome with a distal tubular rather than loop of Henle defect. Nephron 50, 205-211.
33. Reinalter, S., Devlieger, H. & Proesmans, W. 1998. Neonatal Bartter syndrome: spontaneous resolution of all signs and symptoms. Pediatr Nephrol 12, 186-188.
34. Reinalter, S.C., Jeck, N., Brochhausen, C. et al. 2002. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/ante-natal Bartter syndrome. Kidney Int 62, 253-260.
35. Rosenbaum, P. & Hughes, M. 1957. Persistent, probably congenital, hypokalemic metabolic alkalosis with hyaline degeneration of renal tubules and normal urinary aldosterone (Abstract). Am J Dis Child 94, 560.
36. Royer, P., Delaitre, R., Mathieu, H. et al. 1964. L'hypokaliémie chronique idiopathique avec hyperkaliurie de l'enfant. Rev Franc Etudes Clin et Biol, IX, 61-87.
37. Seidel, C., Reinalter, S., Seyberth, H.W. & Scharer, K. 1995. Pre-pubertal growth in the hyperprostaglandin E syndrome. Pediatr Nephrol 9, 723-728.
38. Seyberth, H.W., Rascher, W., Schweer, H. et al. 1985. Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr 107, 694-701.
39. Seyberth, H.W., Koniger, S.J., Rascher, W., Kuhl, P.G. & Schweer, H. 1987. Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediatr Nephrol 1, 491-497.
40. Simon, D.B., Karet, F.E., Hamdan, J.M. et al. 1996a. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13, 183-188.
41. Simon, D.E., Karet, F.E., Rodriguez-Soriano, J. et al. 1996b. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 14, 152-156.
42. Simon, D.B., Nelson-Williams, C., Bia, M.J. et al. 1996c. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12, 24-30.
43. Simon, D.E., Bindra, R.S., Mansfield, T.A. et al. 1997. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 17, 171-178.
44. Sutton, R.A., Mavichak, V., Halabe, A. & Wilkins, G.E. 1992. Bartter's syndrome: evidence suggesting a distal tubular defect in a hypocalciuric variant of the syndrome. Miner Electrolyte Metab 18, 43-51.
45. Verberckmoes, R., van Damme, B.B., Clement, J., Amery, A. & Michielsen, P. 1976. Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin. Kidney Int 9, 302-307.
46. Waldegger, S., Jeck, N., Barth, P. et al. 2002. Barttin increases surface expression and changes current properties of ClC-K channels. Pflugers Arch 444, 411-418.
47. Zelikovic, I., Szargel, R., Hawash, A. et al. 2003. A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int 63, 24-32.